BRITNEY WEVER: Open Payments
NPI 1720380553 · GOTHENBURG, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 60 payments from 14 companies in 2025. Trend: 2023 $708 · 2024 $1,008 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $413 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Grifols USA, LLC | 2 | $50 |
| Lilly USA, LLC | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 3 | $32 |
| Novo Nordisk Inc | 2 | $29 |
| Exact Sciences Corporation | 2 | $28 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: QULIPTA, VRAYLAR, CAPLYTA, Prolastin-C Liquid, UBRELVY, EPKINLY, NURTEC ODT, VOQUEZNA.
Industry payments across NE — which companies pay providers there.
